• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

负载5-氟尿嘧啶的磺胺嘧啶修饰聚乳酸-羟基乙酸共聚物纳米粒的研制及其细胞活力

Development of sulfadiazine-decorated PLGA nanoparticles loaded with 5-fluorouracil and cell viability.

作者信息

Guimarães Pedro Pires Goulart, Oliveira Sheila Rodrigues, de Castro Rodrigues Gabrielle, Gontijo Savio Morato Lacerda, Lula Ivana Silva, Cortés Maria Esperanza, Denadai Ângelo Márcio Leite, Sinisterra Rubén Dario

机构信息

Chemistry Department, Institute of Exact Sciences, Universidade Federal de Minas Gerais, Av. Antonio Carlos, 6627, Pampulha, CEP 31270-901 Belo Horizonte-MG, Brazil.

Department of Restorative Dentistry, Faculty of Dentistry, Universidade Federal de Minas Gerais, Av. Antonio Carlos, 6627, Pampulha, CEP 31270-901 Belo Horizonte-MG, Brazil.

出版信息

Molecules. 2015 Jan 8;20(1):879-99. doi: 10.3390/molecules20010879.

DOI:10.3390/molecules20010879
PMID:25580685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6272719/
Abstract

The aim of this work was to synthesize sulfadiazine-poly(lactide-co-glycolide) (SUL-PLGA) nanoparticles (NPs) for the efficient delivery of 5-fluorouracil to cancer cells. The SUL-PLGA conjugation was assessed using FTIR, 1H-NMR, 13C-NMR, elemental analysis and TG and DTA analysis. The SUL-PLGA NPs were characterized using transmission and scanning electron microscopy and dynamic light scattering. Additionally, the zeta potential, drug content, and in vitro 5-FU release were evaluated. We found that for the SUL-PLGA NPs, Dh = 114.0 nm, ZP = -32.1 mV and the encapsulation efficiency was 49%. The 5-FU was released for up to 7 days from the NPs. Cytotoxicity evaluations of 5-FU-loaded NPs (5-FU-SUL-PLGA and 5-FU-PLGA) on two cancer cell lines (Caco-2, A431) and two normal cell lines (fibroblast, osteoblast) were compared. Higher cytotoxicity of 5-FU-SUL-PLGA NPs were found to both cancer cell lines when compared to normal cell lines, demonstrating that the presence of SUL could significantly enhance the cytotoxicity of the 5-FU-SUL-PLGA NPs when compared with 5-FU-PLGA NPs. Thus, the development of 5-FU-SUL-PLGA NPs to cancer cells is a promising strategy for the 5-FU antitumor formulation in the future.

摘要

这项工作的目的是合成磺胺嘧啶-聚(丙交酯-乙交酯)(SUL-PLGA)纳米颗粒(NPs),以便将5-氟尿嘧啶高效递送至癌细胞。使用傅里叶变换红外光谱(FTIR)、氢核磁共振(1H-NMR)、碳核磁共振(13C-NMR)、元素分析以及热重(TG)和差热分析(DTA)对SUL-PLGA共轭物进行评估。使用透射电子显微镜、扫描电子显微镜和动态光散射对SUL-PLGA NPs进行表征。此外,还评估了zeta电位、药物含量和5-氟尿嘧啶(5-FU)的体外释放情况。我们发现,对于SUL-PLGA NPs,流体力学直径(Dh)= 114.0 nm,zeta电位(ZP)= -32.1 mV,包封率为49%。5-FU从NPs中释放长达7天。比较了负载5-FU的NPs(5-FU-SUL-PLGA和5-FU-PLGA)对两种癌细胞系(Caco-2、A431)和两种正常细胞系(成纤维细胞、成骨细胞)的细胞毒性评估。与正常细胞系相比,发现5-FU-SUL-PLGA NPs对两种癌细胞系均具有更高的细胞毒性,这表明与5-FU-PLGA NPs相比,SUL的存在可显著增强5-FU-SUL-PLGA NPs的细胞毒性。因此,开发5-FU-SUL-PLGA NPs用于癌细胞治疗是未来5-FU抗肿瘤制剂的一种有前景的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e87/6272719/d56a4ef9fbf3/molecules-20-00879-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e87/6272719/2d99592cd807/molecules-20-00879-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e87/6272719/38f1f062679b/molecules-20-00879-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e87/6272719/cd1ab307acb6/molecules-20-00879-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e87/6272719/82d17351ed09/molecules-20-00879-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e87/6272719/bc48b111ae7e/molecules-20-00879-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e87/6272719/10ae61f71917/molecules-20-00879-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e87/6272719/d56a4ef9fbf3/molecules-20-00879-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e87/6272719/2d99592cd807/molecules-20-00879-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e87/6272719/38f1f062679b/molecules-20-00879-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e87/6272719/cd1ab307acb6/molecules-20-00879-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e87/6272719/82d17351ed09/molecules-20-00879-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e87/6272719/bc48b111ae7e/molecules-20-00879-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e87/6272719/10ae61f71917/molecules-20-00879-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e87/6272719/d56a4ef9fbf3/molecules-20-00879-g006.jpg

相似文献

1
Development of sulfadiazine-decorated PLGA nanoparticles loaded with 5-fluorouracil and cell viability.负载5-氟尿嘧啶的磺胺嘧啶修饰聚乳酸-羟基乙酸共聚物纳米粒的研制及其细胞活力
Molecules. 2015 Jan 8;20(1):879-99. doi: 10.3390/molecules20010879.
2
Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.用于将5-氟尿嘧啶递送至胶质瘤癌细胞的转位蛋白配体-PLGA共轭纳米颗粒。
Mol Pharm. 2014 Mar 3;11(3):859-71. doi: 10.1021/mp400536z. Epub 2014 Jan 27.
3
Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA.5-氟尿嘧啶纳米粒用于癌症化疗的生物学评价及其对载体 PLGA 的依赖性。
Int J Nanomedicine. 2011;6:1685-97. doi: 10.2147/IJN.S20165. Epub 2011 Aug 17.
4
Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.透明质酸修饰的 PLGA 纳米粒的制备及表征及其用于 5-氟尿嘧啶的递送。
Drug Deliv. 2010 Nov;17(8):561-72. doi: 10.3109/10717544.2010.500635.
5
Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.壳聚糖包覆的聚(乳酸-共-乙醇酸)纳米粒提高 7-乙基-10-羟基喜树碱口服吸收的机制。
Nanotechnology. 2013 Jun 21;24(24):245101. doi: 10.1088/0957-4484/24/24/245101. Epub 2013 May 23.
6
PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer.聚羟基丁酸戊酸酯/聚乳酸-羟基乙酸共聚物纳米粒增强 5-氟尿嘧啶传递治疗结肠癌的研究进展。
Pharm Dev Technol. 2020 Feb;25(2):206-218. doi: 10.1080/10837450.2019.1684945. Epub 2019 Nov 20.
7
Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy.载多西紫杉醇的星形甘露醇核 PLGA-TPGS 两亲嵌段共聚物纳米粒用于乳腺癌治疗。
Acta Biomater. 2013 Nov;9(11):8910-20. doi: 10.1016/j.actbio.2013.06.034. Epub 2013 Jun 28.
8
Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).六臂星形聚(乳酸-共-乙醇酸)载紫杉醇的合成、表征及评价。
Int J Nanomedicine. 2013;8:4315-26. doi: 10.2147/IJN.S51629. Epub 2013 Nov 7.
9
Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy.伊立替康和5-氟尿嘧啶共载、透明质酸修饰的层层自组装纳米粒用于靶向胃癌治疗
Drug Des Devel Ther. 2017 Sep 5;11:2595-2604. doi: 10.2147/DDDT.S140797. eCollection 2017.
10
Physical PEGylation Enhances The Cytotoxicity Of 5-Fluorouracil-Loaded PLGA And PCL Nanoparticles.物理聚乙二醇化增强了载有 5-氟尿嘧啶的 PLGA 和 PCL 纳米粒子的细胞毒性。
Int J Nanomedicine. 2019 Nov 28;14:9259-9273. doi: 10.2147/IJN.S223368. eCollection 2019.

引用本文的文献

1
Therapeutic effect of F127-folate@PLGA/CHL/IR780 nanoparticles on folate receptor-expressing cancer cells.F127-叶酸@聚乳酸-羟基乙酸共聚物/胆固醇/IR780纳米颗粒对表达叶酸受体的癌细胞的治疗效果。
Beilstein J Nanotechnol. 2024 Jul 31;15:954-964. doi: 10.3762/bjnano.15.78. eCollection 2024.
2
Imiquimod-Loaded Chitosan-Decorated Di-Block and Tri-Block Polymeric Nanoparticles Loaded In Situ Gel for the Management of Cervical Cancer.负载咪喹莫特的壳聚糖修饰二嵌段和三嵌段聚合物纳米颗粒原位凝胶用于宫颈癌治疗
Gels. 2023 Sep 3;9(9):713. doi: 10.3390/gels9090713.
3
Uniaxial and Coaxial Nanofibers PCL/Alginate or PCL/Gelatine Transport and Release Tamoxifen and Curcumin Affecting the Viability of MCF7 Cell Line.

本文引用的文献

1
Preparation of curcumin micelles and the in vitro and in vivo evaluation for cancer therapy.姜黄素胶束的制备及其在癌症治疗中的体内外评价。
J Biomed Nanotechnol. 2014 Aug;10(8):1458-68. doi: 10.1166/jbn.2014.1840.
2
Strategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and market.基于可生物降解聚合物的纳米递送系统靶向肿瘤的策略、知识产权方面以及市场情况。
J Chem Biol. 2012 Nov 30;6(1):7-23. doi: 10.1007/s12154-012-0086-x. eCollection 2012.
3
Validation of the 12-gene colon cancer recurrence score in NSABP C-07 as a predictor of recurrence in patients with stage II and III colon cancer treated with fluorouracil and leucovorin (FU/LV) and FU/LV plus oxaliplatin.
单轴和同轴纳米纤维PCL/藻酸盐或PCL/明胶转运和释放他莫昔芬与姜黄素对MCF7细胞系活力的影响
Nanomaterials (Basel). 2022 Sep 26;12(19):3348. doi: 10.3390/nano12193348.
4
Chemopreventive Effect of 5-Flurouracil Polymeric Hybrid PLGA-Lecithin Nanoparticles against Colon Dysplasia Model in Mice and Impact on p53 Apoptosis.5-氟尿嘧啶聚乳酸-卵磷脂纳米粒对小鼠结肠发育异常模型的化学预防作用及其对p53凋亡的影响
Biomolecules. 2021 Jan 15;11(1):109. doi: 10.3390/biom11010109.
5
Fabrication and Use of Poly(d,l-lactide-co-glycolide)-Based Formulations Designed for Modified Release of 5-Fluorouracil.聚(DL-丙交酯-共-乙交酯)基制剂的制备和应用,旨在控制 5-氟尿嘧啶的释放。
J Pharm Sci. 2018 Feb;107(2):513-528. doi: 10.1016/j.xphs.2017.10.012. Epub 2017 Oct 16.
6
Recent advances of controlled drug delivery using microfluidic platforms.微流控平台控制药物输送的最新进展。
Adv Drug Deliv Rev. 2018 Mar 15;128:3-28. doi: 10.1016/j.addr.2017.09.013. Epub 2017 Sep 15.
7
A biodegradable killer microparticle to selectively deplete antigen-specific T cells in vitro and in vivo.一种可生物降解的杀伤性微粒,用于在体外和体内选择性清除抗原特异性T细胞。
Oncotarget. 2016 Mar 15;7(11):12176-90. doi: 10.18632/oncotarget.7519.
8
Cyclic comonomers for the synthesis of carboxylic acid and amine functionalized poly(L-lactic acid).用于合成羧酸和胺官能化聚(L-乳酸)的环状共聚单体。
Molecules. 2015 Mar 16;20(3):4764-79. doi: 10.3390/molecules20034764.
验证 12 基因结肠癌复发评分在 NSABP C-07 中的作用,作为氟尿嘧啶和亚叶酸(FU/LV)以及 FU/LV 加奥沙利铂治疗的 II 期和 III 期结肠癌患者复发的预测因子。
J Clin Oncol. 2013 Dec 20;31(36):4512-9. doi: 10.1200/JCO.2012.47.3116. Epub 2013 Nov 12.
4
A novel local anti-colorectal cancer drug delivery system: negative lipidoid nanoparticles with a passive target via a size-dependent pattern.一种新型局部抗结直肠癌药物传递系统:通过尺寸依赖性模式的负脂质体纳米粒子的被动靶向。
Nanotechnology. 2013 Sep 20;24(37):375101. doi: 10.1088/0957-4484/24/37/375101. Epub 2013 Aug 21.
5
Controlled release of 5-fluorouracil from microporous zeolites.微孔沸石中 5-氟尿嘧啶的控制释放。
Nanomedicine. 2014 Jan;10(1):197-205. doi: 10.1016/j.nano.2013.06.016. Epub 2013 Aug 3.
6
Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy.载多西紫杉醇的星形甘露醇核 PLGA-TPGS 两亲嵌段共聚物纳米粒用于乳腺癌治疗。
Acta Biomater. 2013 Nov;9(11):8910-20. doi: 10.1016/j.actbio.2013.06.034. Epub 2013 Jun 28.
7
Sulfadiazine modified PDMS as a model material with the potential for the mitigation of posterior capsule opacification (PCO).磺胺嘧啶修饰的聚二甲基硅氧烷作为一种潜在的后囊膜混浊(PCO)缓解模型材料。
Colloids Surf B Biointerfaces. 2013 Nov 1;111:15-23. doi: 10.1016/j.colsurfb.2013.05.002. Epub 2013 May 21.
8
Numerical modelling and experimental investigation of drug release from layered silicone matrix systems.分层硅基质系统中药物释放的数值建模与实验研究。
Eur J Pharm Sci. 2013 Jul 16;49(4):671-8. doi: 10.1016/j.ejps.2013.05.006. Epub 2013 May 14.
9
5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.载 5-氟尿嘧啶的 PLA/PLGA-PEG-PPG-PEG 嵌段共聚物纳米粒的制备、体外评价及细胞培养研究。
Drug Dev Ind Pharm. 2014 Apr;40(4):560-7. doi: 10.3109/03639045.2013.775581. Epub 2013 Apr 18.
10
Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo.介孔硅纳米粒递送最优药物/小干扰 RNA 组合克服乳腺癌的体外和体内多药耐药性
ACS Nano. 2013 Feb 26;7(2):994-1005. doi: 10.1021/nn3044066. Epub 2013 Jan 4.